Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes. / Ørskov, Marie; Vorum, Henrik; Larsen, Torben Bjerregaard; Larsen, Michael; Skjøth, Flemming.

In: American Journal of Medicine, Vol. 136, No. 2, 02.2023, p. 179-185.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ørskov, M, Vorum, H, Larsen, TB, Larsen, M & Skjøth, F 2023, 'Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes', American Journal of Medicine, vol. 136, no. 2, pp. 179-185. https://doi.org/10.1016/j.amjmed.2022.09.012

APA

Ørskov, M., Vorum, H., Larsen, T. B., Larsen, M., & Skjøth, F. (2023). Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes. American Journal of Medicine, 136(2), 179-185. https://doi.org/10.1016/j.amjmed.2022.09.012

Vancouver

Ørskov M, Vorum H, Larsen TB, Larsen M, Skjøth F. Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes. American Journal of Medicine. 2023 Feb;136(2):179-185. https://doi.org/10.1016/j.amjmed.2022.09.012

Author

Ørskov, Marie ; Vorum, Henrik ; Larsen, Torben Bjerregaard ; Larsen, Michael ; Skjøth, Flemming. / Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes. In: American Journal of Medicine. 2023 ; Vol. 136, No. 2. pp. 179-185.

Bibtex

@article{210f7cac83ec40198c07274040d9a32b,
title = "Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes",
abstract = "Background: A characteristic of the retinal circulation is that arterial occlusion is embolic or secondary to vasculitis but rarely or never due to in situ atherosclerosis. Therefore, retinal artery occlusion suggests the presence of cardiac or large-vessel disease outside the eye. This cohort study examined the general risk of macrovascular disease in individuals with diabetes, with or without retinal artery occlusion. Methods: We retrieved data on 992 subjects with incident retinal artery occlusion and preexisting diabetes, registered in Denmark between January 1, 2000, and December 31, 2018. Each retinal artery occlusion subject was matched for age, sex, and diabetes duration, with 5 control subjects with diabetes but without retinal artery occlusion. We performed survival analyses to compare the risk of extraocular macrovascular disease between the 2 groups in a 5-year follow-up. Results: After 1 year, the incidence of macrovascular disease in subjects with retinal artery occlusion was approximately 21 per 100 person-years (95% confidence interval [CI]: 18.11-24.29), compared to 6.25 per 100 patient-years (95% CI: 5.57-7.00) in those without retinal artery occlusion. After 5 years, the cumulative incidences of macrovascular disease were 51.2% (95% CI: 47.9-54.7%) and 29.4% (95% CI: 28.0-30.8%) in patients with diabetes with or without retinal artery occlusion, respectively. Hazard rate ratios were 3.36 (95% CI: 2.79-4.05) after 1 year and 2.27 (95% CI: 2.04-2.53) after 5 years. Conclusion: Among individuals with diabetes, those diagnosed with retinal artery occlusion had a higher general risk of macrovascular complications for at least 5 years after the occlusion event compared with those without retinal artery occlusion.",
keywords = "Diabetic complications, Macrovascular complications, Major adverse cardiovascular event, Retinal artery occlusion",
author = "Marie {\O}rskov and Henrik Vorum and Larsen, {Torben Bjerregaard} and Michael Larsen and Flemming Skj{\o}th",
note = "Funding Information: Funding: This study was partly funded by an unrestricted grant from the Obel Family Foundation and Lions Club Bannerslund . The sponsor did not influence the design or execution of the study. Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",
year = "2023",
month = feb,
doi = "10.1016/j.amjmed.2022.09.012",
language = "English",
volume = "136",
pages = "179--185",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Retinal Artery Occlusion as an Early Indicator of Macrovascular Complications in Diabetes

AU - Ørskov, Marie

AU - Vorum, Henrik

AU - Larsen, Torben Bjerregaard

AU - Larsen, Michael

AU - Skjøth, Flemming

N1 - Funding Information: Funding: This study was partly funded by an unrestricted grant from the Obel Family Foundation and Lions Club Bannerslund . The sponsor did not influence the design or execution of the study. Publisher Copyright: © 2022 Elsevier Inc.

PY - 2023/2

Y1 - 2023/2

N2 - Background: A characteristic of the retinal circulation is that arterial occlusion is embolic or secondary to vasculitis but rarely or never due to in situ atherosclerosis. Therefore, retinal artery occlusion suggests the presence of cardiac or large-vessel disease outside the eye. This cohort study examined the general risk of macrovascular disease in individuals with diabetes, with or without retinal artery occlusion. Methods: We retrieved data on 992 subjects with incident retinal artery occlusion and preexisting diabetes, registered in Denmark between January 1, 2000, and December 31, 2018. Each retinal artery occlusion subject was matched for age, sex, and diabetes duration, with 5 control subjects with diabetes but without retinal artery occlusion. We performed survival analyses to compare the risk of extraocular macrovascular disease between the 2 groups in a 5-year follow-up. Results: After 1 year, the incidence of macrovascular disease in subjects with retinal artery occlusion was approximately 21 per 100 person-years (95% confidence interval [CI]: 18.11-24.29), compared to 6.25 per 100 patient-years (95% CI: 5.57-7.00) in those without retinal artery occlusion. After 5 years, the cumulative incidences of macrovascular disease were 51.2% (95% CI: 47.9-54.7%) and 29.4% (95% CI: 28.0-30.8%) in patients with diabetes with or without retinal artery occlusion, respectively. Hazard rate ratios were 3.36 (95% CI: 2.79-4.05) after 1 year and 2.27 (95% CI: 2.04-2.53) after 5 years. Conclusion: Among individuals with diabetes, those diagnosed with retinal artery occlusion had a higher general risk of macrovascular complications for at least 5 years after the occlusion event compared with those without retinal artery occlusion.

AB - Background: A characteristic of the retinal circulation is that arterial occlusion is embolic or secondary to vasculitis but rarely or never due to in situ atherosclerosis. Therefore, retinal artery occlusion suggests the presence of cardiac or large-vessel disease outside the eye. This cohort study examined the general risk of macrovascular disease in individuals with diabetes, with or without retinal artery occlusion. Methods: We retrieved data on 992 subjects with incident retinal artery occlusion and preexisting diabetes, registered in Denmark between January 1, 2000, and December 31, 2018. Each retinal artery occlusion subject was matched for age, sex, and diabetes duration, with 5 control subjects with diabetes but without retinal artery occlusion. We performed survival analyses to compare the risk of extraocular macrovascular disease between the 2 groups in a 5-year follow-up. Results: After 1 year, the incidence of macrovascular disease in subjects with retinal artery occlusion was approximately 21 per 100 person-years (95% confidence interval [CI]: 18.11-24.29), compared to 6.25 per 100 patient-years (95% CI: 5.57-7.00) in those without retinal artery occlusion. After 5 years, the cumulative incidences of macrovascular disease were 51.2% (95% CI: 47.9-54.7%) and 29.4% (95% CI: 28.0-30.8%) in patients with diabetes with or without retinal artery occlusion, respectively. Hazard rate ratios were 3.36 (95% CI: 2.79-4.05) after 1 year and 2.27 (95% CI: 2.04-2.53) after 5 years. Conclusion: Among individuals with diabetes, those diagnosed with retinal artery occlusion had a higher general risk of macrovascular complications for at least 5 years after the occlusion event compared with those without retinal artery occlusion.

KW - Diabetic complications

KW - Macrovascular complications

KW - Major adverse cardiovascular event

KW - Retinal artery occlusion

U2 - 10.1016/j.amjmed.2022.09.012

DO - 10.1016/j.amjmed.2022.09.012

M3 - Journal article

C2 - 36170938

AN - SCOPUS:85146350197

VL - 136

SP - 179

EP - 185

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -

ID: 370796230